Pre-clinical success for Covid-19 ARDS treatment

Israel’s BrainStorm (reported here previously) reported promising results of pre-clinical trials for its Nurown treatment for Acute Respiratory Distress Syndrome (ARDS) brought about by Covid-19. The NurOwn cells reduced the cytokine storm and lung damage.

https://ir.brainstorm-cell.com/2020-07-23-BrainStorm-Announces-Groundbreaking-Pre-Clinical-Study-of-NurOwn-R-derived-Exosome-Based-Treatment-for-COVID-19-ARDS

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *